Tenet Healthcare Co. (NYSE:THC) Shares Acquired by First Trust Advisors LP

First Trust Advisors LP increased its position in Tenet Healthcare Co. (NYSE:THCGet Rating) by 5.3% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 381,027 shares of the company’s stock after acquiring an additional 19,217 shares during the period. First Trust Advisors LP’s holdings in Tenet Healthcare were worth $18,590,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Parkside Financial Bank & Trust lifted its stake in Tenet Healthcare by 1,063.9% in the 1st quarter. Parkside Financial Bank & Trust now owns 419 shares of the company’s stock valued at $36,000 after buying an additional 383 shares in the last quarter. Lazard Asset Management LLC purchased a new stake in Tenet Healthcare in the 1st quarter valued at approximately $36,000. Beacon Capital Management LLC purchased a new stake in Tenet Healthcare in the 4th quarter valued at approximately $27,000. Point72 Hong Kong Ltd purchased a new stake in Tenet Healthcare in the 1st quarter valued at approximately $78,000. Finally, Captrust Financial Advisors lifted its stake in Tenet Healthcare by 33.5% in the 1st quarter. Captrust Financial Advisors now owns 1,141 shares of the company’s stock valued at $98,000 after buying an additional 286 shares in the last quarter. Hedge funds and other institutional investors own 98.14% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research analysts have weighed in on the company. Barclays increased their price target on Tenet Healthcare from $70.00 to $105.00 in a research note on Wednesday, April 26th. UBS Group increased their price target on Tenet Healthcare from $47.00 to $78.00 and gave the stock a “buy” rating in a research note on Tuesday, February 14th. Raymond James increased their price target on Tenet Healthcare from $72.00 to $85.00 in a research note on Wednesday, April 26th. Truist Financial increased their price target on Tenet Healthcare from $74.00 to $84.00 in a research note on Wednesday, April 26th. Finally, Cantor Fitzgerald assumed coverage on Tenet Healthcare in a research note on Thursday, April 20th. They set an “overweight” rating and a $73.00 price target on the stock. One analyst has rated the stock with a hold rating, fourteen have issued a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, Tenet Healthcare currently has an average rating of “Buy” and an average target price of $75.76.

Insider Transactions at Tenet Healthcare

In other news, Director Tammy Romo sold 7,000 shares of Tenet Healthcare stock in a transaction dated Friday, March 3rd. The stock was sold at an average price of $60.95, for a total transaction of $426,650.00. Following the sale, the director now directly owns 57,598 shares of the company’s stock, valued at $3,510,598.10. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. In related news, EVP Thomas W. Arnst sold 825 shares of Tenet Healthcare stock in a transaction dated Monday, March 6th. The stock was sold at an average price of $61.00, for a total value of $50,325.00. Following the completion of the transaction, the executive vice president now directly owns 22,778 shares in the company, valued at $1,389,458. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Tammy Romo sold 7,000 shares of Tenet Healthcare stock in a transaction dated Friday, March 3rd. The stock was sold at an average price of $60.95, for a total value of $426,650.00. Following the completion of the transaction, the director now owns 57,598 shares of the company’s stock, valued at $3,510,598.10. The disclosure for this sale can be found here. Corporate insiders own 1.30% of the company’s stock.

Tenet Healthcare Stock Down 0.4 %

Shares of NYSE THC opened at $72.88 on Monday. Tenet Healthcare Co. has a 12-month low of $36.69 and a 12-month high of $74.10. The company has a market cap of $7.43 billion, a P/E ratio of 19.43, a P/E/G ratio of 4.78 and a beta of 2.18. The company has a current ratio of 1.39, a quick ratio of 1.29 and a debt-to-equity ratio of 5.79. The stock has a fifty day moving average price of $64.03 and a 200 day moving average price of $55.19.

Tenet Healthcare (NYSE:THCGet Rating) last announced its quarterly earnings results on Tuesday, April 25th. The company reported $1.42 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.16 by $0.26. Tenet Healthcare had a return on equity of 28.65% and a net margin of 2.13%. The firm had revenue of $5.02 billion during the quarter, compared to the consensus estimate of $4.85 billion. During the same period in the prior year, the firm earned $1.93 EPS. The firm’s quarterly revenue was up 5.8% compared to the same quarter last year. Research analysts anticipate that Tenet Healthcare Co. will post 5.69 EPS for the current fiscal year.

Tenet Healthcare Company Profile

(Get Rating)

Tenet Healthcare Corp. engages in the provision of healthcare services. It operates through the following segments: Hospital Operations and Other, Ambulatory Care, and Conifer. The Hospital Operations and Other segment is composed of acute care hospitals, ancillary outpatient facilities, urgent care centers, micro hospitals and physician practices.

Featured Articles

Want to see what other hedge funds are holding THC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Tenet Healthcare Co. (NYSE:THCGet Rating).

Institutional Ownership by Quarter for Tenet Healthcare (NYSE:THC)

Receive News & Ratings for Tenet Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tenet Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.